Skip to content
glp1.howSign in

Mental & Social Health

Disordered eating

A range of irregular or harmful eating behaviors that may not meet the full criteria for a diagnosed eating disorder but still deserve attention and care.

By the glp1.how editorial teamReviewed

Disordered eating describes a range of irregular or harmful eating behaviors, such as frequent restriction, skipping meals, bingeing, purging, or persistent preoccupation with food, weight, or body shape. These patterns may not meet the full diagnostic criteria for an eating disorder like anorexia or bulimia, but they can still affect physical and mental health.

Because appetite and eating patterns can change on GLP-1 medications, these behaviors are worth paying attention to. If eating feels out of control or distressing, it is reasonable to raise it with a clinician or a mental health professional.

mental healtheating behavior

Revision history

Tracked since Jul 18, 2026, no changes yet · show changes
  1. v1

    Change tracking began

Related guides

  • GLP-1 medications and depression: what the evidence shows, and what to watch · Do GLP-1 medications cause depression? The best evidence says no increase in the randomized trials, and in January 2026 the FDA asked for the suicidal-ideation warning to come off the Saxenda, Wegovy and Zepbound labels. Some real-world studies still find a small depression signal, depending on what the drug is compared with, and the months after stopping deserve attention. The drug isn't a depression treatment either. This guide covers the evidence on both sides, what to watch, and when to get help.
  • GLP-1 medications and anxiety: what the evidence shows, and what to watch · Do GLP-1 medications cause anxiety? Large trial data say no overall increase: a 2026 meta-analysis of 86 randomized trials found no link, and the FDA's January 2026 review of 91 trials found no rise in anxiety or other psychiatric events. People still vary. Most stay stable, some feel calmer, and a minority develop new or worse anxiety. It is not a treatment for anxiety. This guide covers the evidence, what to monitor, and when to get help.
  • GLP-1 medications and ADHD: what to know if you have both · ADHD and obesity often go together, so a meaningful number of people on a GLP-1 also have ADHD, and some take a stimulant. There are no trials of GLP-1s as an ADHD treatment, and they shouldn't be used as one. If you have both, three practical things matter: combining two appetite suppressants safely, the overlap between ADHD and eating, and the adherence hurdle a weekly injection poses when you have ADHD.
  • Getting mental health support while on a GLP-1: finding a therapist and the challenges to name · Losing weight on a GLP-1 changes more than your body. Appetite, self-image, coping habits, and how others treat you can all shift, sometimes faster than your mind catches up. This practical guide covers the mental-health challenges people commonly face on these medications, the kinds of professionals who can help, how to find and afford one, and the crisis resources to keep close.
  • GLP-1s and a history of disordered eating: what the evidence says about safety · If you have a history of an eating disorder, or are living with one, a medication that suppresses appetite raises real questions. This guide covers what the early, mixed evidence shows about GLP-1 safety, why an active restrictive disorder is a different situation, and why the decision belongs with a treatment team that includes a mental-health professional.
  • "Taking a GLP-1 is cheating": where the myth comes from, and what the evidence says · "That's cheating" is something many GLP-1 users hear, and sometimes tell themselves. It rests on the belief that weight is a test of willpower and medication is the easy way out. This guide covers what the science of weight regulation shows, where the myth comes from, why it spreads, and how to respond to it.

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.

Was this helpful?

Improve this page